Safety and immunogenicity of a delayed booster dose of the rVSVΔG-ZEBOV-GP vaccine for prevention of Ebola virus disease: a multicentre, open-label, phase 2 randomised controlled trial
Titel:
Safety and immunogenicity of a delayed booster dose of the rVSVΔG-ZEBOV-GP vaccine for prevention of Ebola virus disease: a multicentre, open-label, phase 2 randomised controlled trial
Auteur:
Davey Jr., Richard T Collins, Gary L Rouphael, Nadine Poliquin, Guillaume McConnell, Rosemary Grubbs, Gabrielle Moir, Susan L Langley, Joanne M Teitelbaum, Marc Hewlett, Angela L McLellan, Susan L F Bhadelia, Nahid Raabe, Vanessa N Mulligan, Mark J Maljkovic Berry, Irina Dighero-Kemp, Bonnie Kurtz, Jonathan R Hensley, Lisa E Dozier, Nelson C E Marron, Lindsay C B DuChene, Alain Kuhn, Jens H Brown, Shawn K Khurana, Surender Lane, H Clifford Neaton, James D